T.G. SAKOVETS, E.I. BOGDANOV

 Kazan State Medical University, Kazan

 Contact details:

Sakovets T.G. — PhD (medicine), Associate Professor of the Department of Neurology and Rehabilitation

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-917-924-99-79, e-mail: tsakovets@yandex.ru

Diabetes mellitus (DM) is widespread in Russia, which has caused an increase in the frequency of complications in this nosology, including diabetic autonomic neuropathy (DАN). DАN determines an increase in mortality and a decrease in life expectancy.

The purpose — to study the clinical manifestations of diabetic autonomic neuropathy.

Results. In DAN, a lesion of various organ systems is observed. Manifestations of DAN are usually preceded by the development of typical signs of distal sensorimotor polyneuropathy. In some patients, manifestations of damage to the autonomic nervous system may prevail over damage to somatic sensory and motor nerve fibers. It should be borne in mind that in more than half of cases, DAN is accompanied by a fatal outcome with a duration of DM of more than 10 years. Cardiovascular autonomic neuropathy (CAN), which determines life expectancy in DM, is most often studied in the modern Russian and foreign medical science. The studies of other DAN manifestations are presented with much less frequency. DAN is accompanied by damage to all parts of the autonomic nervous system and determines an increase in mortality in patients with DM, which requires early detection of signs of diabetic autonomic neuropathy.

Conclusion. Thus, DAN can cause an increase in mortality, a persistent decrease in working capacity in patients with DM, which requires general practitioners to be aware of the features of clinical signs of this nosology.

Key words: diabetes mellitus, diabetic neuropathy, diabetic autonomic neuropathy.

REFERENCES

1. Anisimova E.I., Danilova A.B. Neuropathic pain syndrome: clinical and neurophysiological analysis. Zhurnal nevrologii i psikhiatrii, 2003, vol. 103, no. 10, pp. 15–20 (in Russ.).
2. Bogdanov E.I., Sakovets T.G., Gil’mullin I.F. The effect of cerebrolysin therapy on the dynamics of manifestations of diabetic polyneuropathy. Zhurnal nevrologii i psikhiatrii, 2009, vol. 109, no. 9, pp. 31–34 (in Russ.).
3. Shima A.F., Kamiya H. Diabetic neuropathy differs in type1 and type 2 diabetes. Ann. N.Y. Acad. Sci, 2006, vol. 1084, pp. 235–249.
4. Torsvik M., Haggblom A., Eide G.E. et al. Cardiovascular autonomic function tests in an African population. Endocrine disorders, 2008, vol. 19 (8), pp. 1–10.
5. Dyck P.J., Melton L.J., O, Brien et al. Current state and respectives of Diabetes Research: Chronic Complications. Diabetes, 1997, vol. 46 (2), pp. 5–8.
6. Sinnreich M., Taylor B.V., Dyck P.J. Diabetic neuropathies. Classification, clinical features and pathophysiological basis. Neurol, 2005, vol. 11 (2), pp. 63–79.
7. Tesfaye S., Stevens L.K., Stephenson J.M. et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complication study. Diabetolog, 1996, vol. 39, pp. 1377–1384.
8. Strokov I.A. Pharmacotherapy of diabetic polyneuropathy: reality and prospects. Nevrol. zhurn, 2001, no. 5, pp. 4–8 (in Russ.).
9. Oyibo S.O., Prasad Y.D., Jacson N.J. et al. The relationship between blood glucose excursions and painful diabetic peripheral diabetic neuropathy: a pilot study. Diabet. Med, 2002, vol. 19, pp. 870–873.
10. Dobretsov M., Hastings S.L., Romanovsky D. et al. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res, 2003, vol. 960, pp. 174–183.
11. Douglas W., Zochodne M.D. Diabetes mellitus and the peripherial nervous system: manifestation and mechanisms. Muscle nerves, 2007, vol. 36, pp. 144–166.
12. Zeigler D., Laux G., Daniel K. et al. Assessment of cardiovascular autonomic function: age-related normal rages and reproducibility of spectral analysis, vector analysis and standard rate of heart rate variation and blood pressure responses. Diabetic. Med, 1992, vol. 9, pp. 166–175.
13. Vinik A., Richardson D. Erectile dysfunction in diabetes. Diabetes Rev, 1998, vol. 6, pp. 16–33.
14. Bogdanov E.I., Talantov V.V., Mukhametzyanov R.Z. Nevrologicheskie oslozhneniya sakharnogo diabeta: metodicheskoe posobie. Ch. I [Neurological complications of diabetes mellitus: a manual. Part I]. Kazan: KGMU, 2000. 25 p.
15. Unger J., Cole B.E. Recognition and management of diabetic neuropathy. Prim care clin office pract, 2007, vol. 34, pp. 887–913.
16. Vardi Y., Sprecher E., Kantwer Y. et al. Polyneuropathy in impotance. Int. J. Impot. Res, 1996, vol. 2 (8), pp. 65–68.
17. Boulton A.J., Vinik A.I., Arezzo J.C. et al Diabetic neuropathies: a statement by American Diabetes Assosiation. Diabetes Care, 2005, vol. 28 (4), pp. 956–962.
18. Rozhivanov R.V., Kalinichenko S.Yu. Neurological criteria of neurogenic erectile dysfunction diagnostics in patients with diabetic. Androl, 2004, vol. 36 (4), p. 193.
19. Hakim L.S., Goldstein I. Diabetic sexual dyseunction. Endocrinol. Metab. Clin. North Am, 1996, vol. 25, pp. 379–400.
20. O Hare J.A., Abuaisha F., Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir. J. Med. Sci, 1994, vol. 163, pp. 132–135.